Publications and presentations
AVEO Oncology allows you to access a number of published papers and presentations outlining our clinical data that were given at premier conferences and symposia around the world.
Updated overall survival in patients with prior checkpoint inhibitor therapy in the phase III TIVO-3 study
Authors: Miguel Zugman, David F. McDermott, Bernard J. Escudier, Thomas E. Hutson, Camillo Porta, Elena Verzoni, Michael B. Atkins, Brian Rini, Sumanta K. Pal. Click here for link to article.
Estimated cost of VEGFR TKI associated adverse events in metastatic renal cell carcinoma patients
Authors: Jeffrey Thomas Yorio, Aviva G. Asnis-Alibozek, Vijay Kasturi, Thomas E. Hutson. Click here for link to article.
Advanced Human Papillomavirus–Negative Head and Neck Squamous Cell Carcinoma: Unmet Need and Emerging Therapies
Authors: Robin Park, Christine H. Chung. Click here for link to article.
Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study
Authors: Toni K. Choueiri, Laurence Albiges, Philippe Barthélémy, Roberto Iacovelli, Sheik Emambux, Javier Molina-Cerrillo, Benjamin Garmezy, Pedro Barata, Arnab Basu, Maria T. Bourlon, Helen Moon, Raffaele Ratta, Rana R. McKay, Alexander Chehrazi-Raffle, Hans Hammers, Daniel Y. C. Heng, Edgar Braendle, Kathryn E. Beckermann, Bradley A. McGregor, Robert J. Motzer. Click here for link to article.